search
Back to results

Intrathecal Hydromorphone for Labor Analgesia

Primary Purpose

Labor Pain

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Hydromorphone
Sponsored by
Emory University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Labor Pain

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy patients
  • Labor
  • Desires pain relief

Exclusion Criteria:

  • Any comorbidities other than obesity

Sites / Locations

  • Grady Memorial Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Hydromorphone

Arm Description

Laboring patients receive ED50 of hydromorphone one time intrathecally

Outcomes

Primary Outcome Measures

Pain Score, Visual Analogue Pain Scores
Continuous Visual Analogue Scale 0 - 10 (0=no pain, 10=worst imaginable pain).

Secondary Outcome Measures

Pain Scores, Visual Analogue Pain Scale
Continuous Visual Analogue Scale 0 - 10 (0=no pain, 10=worst imaginable pain).

Full Information

First Posted
May 10, 2012
Last Updated
December 14, 2017
Sponsor
Emory University
search

1. Study Identification

Unique Protocol Identification Number
NCT01598506
Brief Title
Intrathecal Hydromorphone for Labor Analgesia
Official Title
Determination of the ED50 of Intrathecal Hydromorphone in Laboring Women Using the Up-and-down Sequential Allocation Method
Study Type
Interventional

2. Study Status

Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
September 2013 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
February 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Emory University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will investigate the dose of hydromorphone which will relieve the pain of women in labor when delivered directly in the area around the spinal cord (i.e., intrathecal injection). The primary objective is to determine the dose of intrathecal hydromorphone that results in a pain score of less than 4 out of 10 thirty minutes after intrathecal injection in 50% of women. Secondary objectives include determining this dose at five and ten minutes after injection. Thirty women admitted to labor and delivery for planned vaginal delivery desiring epidural placement will be consented for the study. The starting dose of intrathecal hydromorphone will be 6 mcg. The up-and-down sequential allocation method of statistical analysis will be used, meaning that each subsequent dose will be dependent upon the result obtained from the prior dose - ergo, if the initial subject has pain relief, the second subject will receive 4 mcg (2 mcg less), but if the initial subject does not have pain relief, the second subject will receive 8 mcg (2 mcg more) of hydromorphone. After the intrathecal injection is given and the epidural is placed, visual analogue pain scores will be assessed 60 minutes following injection. A pain score of less than three will be a positive result. A pain score of three or greater will be a negative result. Blood pressure, heart rate, arterial oxygen saturation, fetal heart rate, and any side effects will also be assessed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Labor Pain

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Single Group Assignment
Masking
Outcomes Assessor
Allocation
N/A
Enrollment
22 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Hydromorphone
Arm Type
Experimental
Arm Description
Laboring patients receive ED50 of hydromorphone one time intrathecally
Intervention Type
Drug
Intervention Name(s)
Hydromorphone
Intervention Description
Hydromorphone will be administered one time intrathecally to laboring patients to determine the ED50 for pain relief.
Primary Outcome Measure Information:
Title
Pain Score, Visual Analogue Pain Scores
Description
Continuous Visual Analogue Scale 0 - 10 (0=no pain, 10=worst imaginable pain).
Time Frame
30 minutes after intrathecal injection
Secondary Outcome Measure Information:
Title
Pain Scores, Visual Analogue Pain Scale
Description
Continuous Visual Analogue Scale 0 - 10 (0=no pain, 10=worst imaginable pain).
Time Frame
Baseline

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy patients Labor Desires pain relief Exclusion Criteria: Any comorbidities other than obesity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Grant C Lynde, MD
Organizational Affiliation
Emory University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Grady Memorial Hospital
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30303
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
30290794
Citation
O'Reilly-Shah V, Lynde GC. Determination of ED50 and time to effectiveness for intrathecal hydromorphone in laboring patients using Dixon's up-and-down sequential allocation method. BMC Anesthesiol. 2018 Oct 5;18(1):140. doi: 10.1186/s12871-018-0603-8.
Results Reference
derived

Learn more about this trial

Intrathecal Hydromorphone for Labor Analgesia

We'll reach out to this number within 24 hrs